SANOFI (SAN.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:SAN • FR0000120578

80.36 EUR
-0.73 (-0.9%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

SAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While SAN is still in line with the averages on profitability rating, there are concerns on its financial health. SAN has a decent growth rate and is not valued too expensively. Finally SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SAN had positive earnings in the past year.
  • SAN had positive earnings in each of the past 5 years.
  • In the past 5 years SAN always reported a positive cash flow from operatings.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SAN has a better Return On Assets (10.63%) than 76.36% of its industry peers.
  • Looking at the Return On Equity, with a value of 18.84%, SAN is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
  • SAN's Return On Invested Capital of 13.35% is fine compared to the rest of the industry. SAN outperforms 65.45% of its industry peers.
  • SAN had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 14.23%.
  • The 3 year average ROIC (7.41%) for SAN is below the current ROIC(13.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SAN's Profit Margin of 20.63% is fine compared to the rest of the industry. SAN outperforms 80.00% of its industry peers.
  • In the last couple of years the Profit Margin of SAN has declined.
  • The Operating Margin of SAN (23.61%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SAN has grown nicely.
  • SAN has a Gross Margin of 72.29%. This is comparable to the rest of the industry: SAN outperforms 50.91% of its industry peers.
  • In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
  • Compared to 1 year ago, SAN has less shares outstanding
  • Compared to 5 years ago, SAN has less shares outstanding
  • Compared to 1 year ago, SAN has a worse debt to assets ratio.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • SAN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: SAN outperforms 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.71
WACC7.8%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SAN has a Current Ratio of 1.06. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.06, SAN is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • SAN has a Quick Ratio of 1.06. This is a bad value and indicates that SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.30, SAN is doing worse than 89.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.39%.
  • SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.37% yearly.
  • Looking at the last year, SAN shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
  • Measured over the past years, SAN shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%

3.2 Future

  • Based on estimates for the next years, SAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.19% on average per year.
  • The Revenue is expected to grow by 5.52% on average over the next years.
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.41 indicates a reasonable valuation of SAN.
  • Compared to the rest of the industry, the Price/Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 87.27% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, SAN is valued rather cheaply.
  • SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.51.
  • SAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 89.09% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.78, SAN is valued rather cheaply.
Industry RankSector Rank
PE 11.41
Fwd PE 9.51
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SAN may justify a higher PE ratio.
  • SAN's earnings are expected to grow with 12.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)3.38
EPS Next 2Y12.73%
EPS Next 3Y12.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.08%, SAN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.89, SAN pays a better dividend. On top of this SAN pays more dividend than 94.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.08%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • SAN pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

EPA:SAN (2/6/2026, 7:00:00 PM)

80.36

-0.73 (-0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap194.09B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts79.31
Price Target100.14 (24.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.08%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-4.87%
PT rev (3m)-4.86%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-2.58%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 11.41
Fwd PE 9.51
P/S 2.9
P/FCF N/A
P/OCF N/A
P/B 2.65
P/tB 44.15
EV/EBITDA N/A
EPS(TTM)7.04
EY8.76%
EPS(NY)8.45
Fwd EY10.52%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)0.57
PEG (5Y)3.38
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.8%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y10.94%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 11.41 and the Price/Book (PB) ratio is 2.65.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 3 / 10.